ArticleSurgical endoscopy2025
Assessment of the safety and efficacy of robotic versus laparoscopic gastrectomy in overweight patients with gastric cancer: a large-scale multicenter cohort study.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
backgroundThe comparative efficacy of robotic (RG) and laparoscopic gastrectomy (LG) in patients with gastric cancer with a body mass index (BMI) ≥ 25 kg/m
methodsThis multicenter cohort study included 695 patients with gastric cancer with BMI ≥ 25 kg/m
resultsAfter OW and IPTW adjustments, the two groups' baseline characteristics were well-balanced. Intraoperative blood loss, major bleeding rates, number of perioperative transfusions, and incidence of medical complications were lower, while operative time and costs were greater in the RG than LG group (all P < 0.05). Postoperative pneumonia rates tended to be lower in the RG group. The 3-year disease-free survival (DFS) or overall survival (OS) were comparable between groups. Subgroup analyses revealed no statistically significant interactions between the surgical approach and DFS or OS across all variables (all interactions, P > 0.05). Recurrence rates and patterns were comparable between the groups (all P > 0.05).
conclusionFor patients with gastric cancer with BMI ≥ 25 kg/m
Indexed as
Identifiers
40715653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.